Black Bird Biotech, Inc.
BBBT
$0.0002
$0.0001100.00%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| Weiss Ratings | BBBT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | BBBT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | BBBT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.25 | |||
| Price History | BBBT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | -50.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | -50.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -80.00% | |||
| 2-Year Total Return | -99.00% | |||
| 3-Year Total Return | -99.66% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -78.57% | |||
| 52-Week Low % Change | 14,900.00% | |||
| Price | BBBT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Dec 26, 2023 | |||
| 52-Week High Price (Date) | Jun 15, 2023 | |||
| Valuation | BBBT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 447.28K | |||
| Enterprise Value | 1.37M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | -80.25% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -0.30 | |||
| Enterprise Value/Revenue (TTM) | 37.74 | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -52.69 | |||
| Enterprise Value/EBIT | -4.35 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | BBBT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 1.92B | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | BBBT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 833 223 4204 | |||
| Address | 11961 Hilltop Road Argyle, TX 76226 | |||
| Website | www.blackbirdbiotech.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | BBBT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -866.94% | |||
| Profit Margin | -2,303.30% | |||
| Management Effectiveness | BBBT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -147.17% | |||
| Return on Equity | -- | |||
| Income Statement | BBBT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 36.30K | |||
| Total Revenue (TTM) | 36.30K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | -13.30K | |||
| EBITDA (TTM) | -26.00K | |||
| EBIT (TTM) | -314.70K | |||
| Net Income (TTM) | -836.10K | |||
| Net Income Avl. to Common (TTM) | -836.10K | |||
| Total Revenue Growth (Q YOY) | -84.82% | |||
| Earnings Growth (Q YOY) | 41.64% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | 87.50% | |||
| Balance Sheet | BBBT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 5.70K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 91.10K | |||
| Total Preferred Equity (Q) | 0.00 | |||
| Total Equity (Q) | -922.80K | |||
| Current Ratio (Q) | 0.089 | |||
| Book Value Per Share (Q) | $0.00 | |||
| Total Assets (Q) | 98.80K | |||
| Total Current Liabilities (Q) | 1.02M | |||
| Total Debt (Q) | 928.30K | |||
| Total Liabilities (Q) | 1.02M | |||
| Total Common Equity (Q) | -922.80K | |||
| Cash Flow | BBBT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 172.60K | |||
| Net Change in Cash (TTM) | -60.40K | |||
| Levered Free Cash Flow (TTM) | -84.80K | |||
| Cash from Operations (TTM) | -233.00K | |||
